Penta Valent

PEVE · JK · Healthcare / Pharmaceutical Retailers

322.00IDR+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close322.00

Open320.00

Day Range320.00 – 328.00

52-Week Range254.00 – 670.00

Volume51.30K

Market Cap568.53B

P/E (TTM)0.00

Forward P/E0.00

Dividend Yield0.00%

Beta-0.20

50-Day Avg319.44

200-Day Avg418.46

About

PT. Penta Valent Tbk engages in the distributions of pharmaceutical products, medical equipment, and consumer products in Indonesia. The company was founded in 1968 and is headquartered in Kebon Jeruk, Indonesia.

Company Details

SectorHealthcare
IndustryPharmaceutical Retailers
CEOMr. . Sukismo
Employees1.50K
HeadquartersJl. Kedoya Raya No. 33, Kebon Jeruk, Indonesia, 11520, Indonesia
Websitehttps://www.pentavalent.co.id

Leadership

Mr. . SukismoPresident Director · b. 1954
Mr. Franxiscus Afat Adinata NursalimFinance Director & Director · b. 1971
Gunawan Hadi KartonoCorporate Secretary · b. 1975

Financials

Income Statement

Currency: IDR	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	2.15T	2.48T	3.01T	3.55T
Growth (%)	-	+15.71%	+21.25%	+17.77%
Cost of Revenue	1.92T	2.18T	2.66T	3.17T
Gross Profit	230.29B	302.47B	348.98B	376.85B
Gross Margin	10.72%	12.17%	11.58%	10.62%
Operating Expense	194.88B	253.46B	283.10B	288.92B
Operating Income	35.41B	49.01B	65.89B	87.93B
Operating Margin	1.65%	1.97%	2.19%	2.48%
Net Income	23.55B	36.17B	48.01B	55.33B
Net Income Margin	1.10%	1.46%	1.59%	1.56%

Balance Sheet

Currency: IDR	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	743.96B	906.74B	1.16T	1.39T
Total Liabilities	597.16B	674.53B	876.52B	1.04T
Total Equity	146.80B	232.21B	286.99B	345.97B
Cash	-	4.49B	7.78B	13.19B

Cash Flow

Currency: IDR	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-17.99B	-61.11B	-93.13B	-118.55B
Investing Cash Flow	-9.42B	-8.22B	-12.46B	-14.30B
Financing Cash Flow	29.61B	68.13B	108.88B	138.25B
Capital Expenditure	9.68B	8.41B	12.63B	12.96B
Dividends Paid	78.60B	-	-	-

Earnings

Report Date	Mar 31, 2023	Jun 30, 2023
EPS Estimate	-	-
EPS Actual	3.59	4.58
Surprise	-	-
Timing	-	-

Key Statistics & Ratios

Market Cap568.53B

Enterprise Value547.34B

Trailing P/E0.00

Forward P/E0.00

Price / Sales0.15

Price / Book0.00

Book Value213.56

Revenue (TTM)3.70T

Gross Profit (TTM)400.15B

EBITDA95.25B

Profit Margin1.55%

Operating Margin2.55%

Return on Equity16.31%

Return on Assets4.18%

Shares Outstanding1.77B

Shares Float324.88M

Beta-0.20

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%